SCP
AGN

Scoria Capital Partners’s Allergan plc AGN Stock Holding History

Scoria Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,600
Closed -$3.5M – 193
2014
Q4 		$3.5M Buy
+13,600
New +$3.4M 1.58% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Scoria Capital Partners's AGN Position: Q1 2015 in Review

Scoria Capital Partners sold out of Allergan plc (AGN) in Q1 2015, closing a stake of 13,600 shares — an estimated $3.5M sold.

Scoria Capital Partners first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $3.5M in Q4 2014. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Scoria Capital Partners reported no remaining Allergan plc position as of Q1 2015 after selling out during the quarter.
  • Scoria Capital Partners sold 13,600 Allergan plc shares in Q1 2015, an estimated $3.5M.
  • Scoria Capital Partners first reported a position in Allergan plc in Q4 2014 and held it in 1 quarter.
  • Scoria Capital Partners's Allergan plc position peaked at $3.5M in Q4 2014.
  • 1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Scoria Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.